Zenlabs Ethica Ltd
Zenlabs Ethica Ltd Live Price Chart
Performance
| Previous Close | ₹ |
| High | ₹ |
| Volume | 2187 |
| 52W Range | ₹ - ₹ |
| Open | ₹ |
| Low | ₹ |
| Market Cap | ₹ 16 Cr |
Zenlabs Ethica Ltd Technicals
| 20 Day | ₹ 19.366 |
| 50 Day | ₹ 19.992 |
| 100 Day | ₹ 21.927 |
| 200 Day | ₹ 25.487 |
| 20 Day | ₹ 19.250 |
| 50 Day | ₹ 19.638 |
| 100 Day | ₹ 21.627 |
| 200 Day | ₹ 26.896 |
Zenlabs Ethica Ltd Fundamentals
| ROCE | 5.829 |
| P/E Ratio | -7.270 |
| P/B Ratio | 1.270 |
| Industry P/E | 1.270 |
| Debt to Equity | 39.708 |
| ROE | 2.338 |
| EPS | -2.840 |
| Dividend Yield | 0.000 |
| Book Value | 16.206 |
| Face Value | 10.000 |
Zenlabs Ethica Ltd Financials
| Particulars | Y202503 | Y202403 | Y202303 | Y202203 | Y202103 |
|---|---|---|---|---|---|
| Total Revenue | 51.4705 | 58.8623 | 67.0148 | 69.1751 | 56.7643 |
| Total Expenses | 51.0426 | 58.2808 | 65.765 | 67.954 | 55.9043 |
| Profit After Tax | 0.2692 | 0.4212 | 0.4893 | 0.7821 | 0.7674 |
Zenlabs Ethica Ltd Shareholding Pattern
| Promoter Holdings | 52.961 % |
| FIIs | 0.000 % |
| DIIs | 0.000 % |
| MutualFund | 0.000 % |
| Retail | 38.597 % |
| Others - | 8.443 % |
About Zenlabs Ethica Ltd
Zenlabs Ethica Limited was initially incorporated in the name of Neelkanth Technologies Limited on 20 July, 1993. With the due approval from the Registrar of Companies, Ministry of Corporate Affairs, name of the Company was changed to Zenlabs Ethica Limited in 2016-17. The Company is one of the top 10 pharmaceutical contract manufacturing companies in India that develops, markets and exports a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti Hypertensive Drugs, Anti-Infective, Soaps & Anti Bacterial Drugs, Nutraceuticals, etc. The company has been launched in collaboration with Zenlabs Pharmaceutical Inc, Canada. It offers more than 600 products across therapeutic segments, making it a leader among pharmaceutical companies in India. In 2023, the Company ventured into diversified segments like Neurology and Cytrics. ...
